US provides Ebola treatment for outbreak in Congo, bringing trials closer
The United States is shipping experimental antiviral treatments to the Democratic Republic of Congo to support upcoming clinical trials for the Ebola outbreak.
📍 How it ended
The US provided an experimental Ebola drug for trials in the Democratic Republic of Congo, with the World Health Organization announcing two trials of experimental drugs in the Ebola outbreak. The response to the Ebola outbreak in the Democratic Republic of Congo began to show positive results according to the WHO. The story quieted without further updates on the outcome of the trials.
Epilogue added 41d ago, after coverage quieted.
The obvious questions
What treatments are being tested?
The clinical trials will test two experimental antiviral treatments developed by Mapp and Gilead.
When will the clinical trials begin?
According to the World Health Organization, the trials are scheduled to start next week.
Has the US provided funding in addition to the drug shipment?
Yes, the U.S. has committed $50 million to develop countermeasures for the Bundibugyo Ebola strain.
The story so far
Department of Health and Human Services has sent experimental drugs to the Democratic Republic of Congo. The deployment is intended to support the initiation of clinical trials, which are scheduled to begin next week. These trials will evaluate two specific antiviral treatments, identified by the World Health Organization as products from Mapp and Gilead.
Coverage from outlets including Reuters, NBC News, STAT, and CIDRAP highlights the involvement of advocacy groups who pushed for the international sharing of these supplies. The World Health Organization is coordinating the response, reporting that initial efforts are showing results as the total number of cases surpasses 1000. Reports from Global Biodefense note an additional financial commitment of $50 million from the U.S. directed toward developing countermeasures specifically for the Bundibugyo Ebola strain.
Future reports will track the commencement of the clinical trials and the distribution of these experimental antibodies. Coverage does not yet specify the timeline for preliminary data release or the long-term logistical plans for the drug rollout.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 41d ago.
Coverage (14)
- US to provide new experimental Ebola drug Yahoo · 45d ago
- WHO: Response to Ebola Outbreak in Democratic Republic of Congo Begins to Bear Fruit وكالة سبأ · 45d ago
- WHO announces 2 trials of experimental drugs in Ebola outbreak CIDRAP · 45d ago
- U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC Outbreak Global Biodefense · 45d ago
- Advocacy groups urge US to share experimental Ebola drug for outbreak trials The Straits Times · 45d ago
- HHS has sent drug for Ebola clinical trial statnews.com · 46d ago
- Trials of two Ebola treatments to start in DRC next week: WHO Medical Xpress · 46d ago
- Trials of two Ebola treatments to start in DRC next week: WHO CTV News · 46d ago
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief Fierce Biotech · 46d ago
- As Ebola Cases Breach 1000, Trial Of Two Antiviral Treatments Due To Start Soon Health Policy Watch · 46d ago
- Experts urge use of experimental antibodies in DR Congo to combat Ebola CIDRAP · 46d ago
- Clinical trial set to test two drugs for fast-growing Ebola outbreak statnews.com · 46d ago
- U.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer NBC News · 46d ago
- US provides Ebola treatment for outbreak in Congo, bringing trials closer Reuters · 46d ago
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Uganda declares end to Ebola outbreak
Uganda has officially declared its latest Ebola outbreak over, even as neighboring Congo continues to struggle with the virus.
First person gets new experimental vaccine for Ebola
The first human participant has received an experimental vaccine targeting the Bundibugyo ebolavirus strain as clinical trials launch in the DRC.
Exclusive: A couple paid more than $800,000 for a gene-editing therapy for their daughter. She died, and it wasn’t made public
A report reveals the death of a 6-year-old child following an experimental gene-editing treatment in China that was not disclosed to the public.
‘There’s no salary’: DRC health workers tell of hardship as Ebola spreads
Ebola cases approach 3,000 in the Democratic Republic of Congo as labor strikes and ongoing violence hinder containment efforts.
At least 930 people have died in Congo's Ebola outbreak
The Ebola outbreak in the Democratic Republic of the Congo has surpassed 1,000 fatalities, with reports describing it as the fastest-spreading in history.
Antibiotic-resistant bacteria increasingly leaving children vulnerable to common infections, global study finds
A new global study indicates that antibiotic-resistant bacteria are leaving children increasingly vulnerable to common infections.